Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole

References

• ShermanPMHassallEFagundes-NetoUA global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric populationAm J Gastroenterol20091041278129519352345
   PubMed Web of Science ®Google Scholar
• VandenplasYRudolphCDDi LorenzoCPediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)J Pediatr Gastroenterol Nutr20094949854719745761
   PubMed Web of Science ®Google Scholar
• VakilNvan ZantenSVKahrilasPDentJJonesRGlobal Consensus GroupThe Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensusAm J Gastroenterol20061011900192016928254
   PubMed Web of Science ®Google Scholar
• GunasekaranTSDahlbergMRameshPNamachivayamGPrevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school populationDig Dis Sci2008532373237918204971
   PubMed Web of Science ®Google Scholar
• MooreDJTaoBSLinesDRHirteCHeddleMLDavidsonGPDouble-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal refluxJ Pediatr200314321922312970637
   PubMed Web of Science ®Google Scholar
• ArmstrongKPreviteraNMcCallumRMedicalizing normality? Management of irritability in babiesJ Paediatr Child Health20003630130510940159
   PubMed Web of Science ®Google Scholar
• NelsonSPChenEHSyniarGMChristoffelKKPrevalence of symptoms of gastroesophageal reflux during childhood: A pediatric practice-based survey. Pediatric Practice Research GroupArch Pediatr Adolesc Med200015415015410665601
   PubMed Web of Science ®Google Scholar
• SavarinoVdi MarioFScarpignatoCProton pump inhibitors in GORD: An overview of their pharmacology, efficacy and safetyPharmacol Res20095913515318977444
   PubMed Web of Science ®Google Scholar
• GuimarãesEVMarguetCCamargosPAMTreatment of gastroesophageal reflux diseaseJ Pediatr (Rio J).200682Suppl 5S13314517136289
   PubMedGoogle Scholar
• CraigWRHanlon-DearmanASinclairCTabackSMoffattMMetoclopramide, thickened feedings, and positioning for gastrooesophageal reflux in children under two yearsCochrane Database Syst Rev2004CD00350215495056
   PubMedGoogle Scholar
• TobinJMMcCloudPCameronDJPosture and gastrooesophageal reflux: A case for left lateral positioningArch Dis Child1997762542589135268
   PubMed Web of Science ®Google Scholar
• OyenNMarkestadTSkaervenRCombined effects of sleeping position and prenatal risk factors in sudden infant death syndrome: The Nordic Epidemiological SIDS StudyPediatrics19971006136219310514
   PubMed Web of Science ®Google Scholar
• JefferyHEMegevandAPageHWhy the prone position is a risk factor for sudden infant death syndromePediatrics9991042 Pt 126326910429005
   PubMedGoogle Scholar
• BaguckaBde SchepperJPeelmanMvan de MaeleKVandenplasYAcid gastroesophageal reflux in the 10 degrees reversed-Trendelenburg-position in supine sleeping infantsActa Paediatr Taiwan19994029830110910536
   PubMedGoogle Scholar
• WenzlTGSchneiderSScheeleFSilnyJHeimannGSkopnikHEffects of thickened feeding on gastroesophageal reflux in infants: A placebo-controlled crossover study using intraluminal impedancePediatrics.20031114 Pt 1e355e35912671151
   PubMed Web of Science ®Google Scholar
• RudolphCDMazurLJLiptakGSGuidelines for evaluation and treatment of gastroesophageal reflux in infants and children: Recommendations of the North American Society for Pediatric Gastroenterology and NutritionJ Pediatr Gastroenterol Nutr200132Suppl 2S13111525610
   PubMed Web of Science ®Google Scholar
• VandenplasYBadriulHVerghoteMOesophageal pH monitoring and reflux oesophagitis in irritable infantsEur J Pediatr200416330030415346910
   PubMed Web of Science ®Google Scholar
• HeineRGCameronDJChowCWEsophagitis in distressed infants: Poor diagnostic agreement between esophageal pH monitoring and histopathologic findingsJ Pediatr2002140141911815758
   PubMed Web of Science ®Google Scholar
• ScarupaMDMoriNCanningBJGastroesophageal reflux disease in children with asthma: Treatment implicationsPaediatr Drugs2005717718615977963
   PubMedGoogle Scholar
• CondinoAASondheimerJPanZEvaluation of gastroesophageal reflux in pediatric patients with asthma using impedance-pH monitoringJ Pediatr200614921621916887437
   PubMed Web of Science ®Google Scholar
• StordalKJohannesdottirGBBentsenBSAcid suppression does not change respiratory symptoms in children with asthma and gastrooesophageal reflux diseaseArch Dis Child20059095696016113133
   PubMed Web of Science ®Google Scholar
• GoldBDIs gastroesophageal reflux disease really a life-long disease: Do babies who regurgitate grow up to be adults with GERD complicationsAm J Gastroenterol200610164164416542297
   PubMed Web of Science ®Google Scholar
• HassallEKerrWEl-SeragHBCharacteristics of children receiving proton pump inhibitors continuously for up to 11 years durationJ Pediatr200715026226717307542
   PubMed Web of Science ®Google Scholar
• ChibaNde GaraCJWilkinsonJMHuntRHSpeed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysisGastroenterology1997112179818109178669
   PubMed Web of Science ®Google Scholar
• CucchiaraSMinellaRIervolinoCOmeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitisArch Dis Child1993696556598285777
   PubMed Web of Science ®Google Scholar
• HassallEIsraelDShepherdROmeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study GroupJ Pediatr200013780080711113836
   PubMed Web of Science ®Google Scholar
• FrancoMTSalviaGTerrinGLansoprazole in the treatment of gastrooesophageal reflux disease in childhoodDig Liver Dis20003266066611142573
   PubMedGoogle Scholar
• FiedorekSToliaVGoldBDEfficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux diseaseJ Pediatr Gastroenterol Nutr20054031932715735486
   PubMed Web of Science ®Google Scholar
• TsouVMBakerRBookLMulticenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD)Clin Pediatr (Phila)20064574174916968960
   PubMed Web of Science ®Google Scholar
• JamesLWalsonPLomaxKKaoRVarugheseSReyesJPharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: An open-label, single-and multiple-dose studyClin Ther2007292082209218035206
   PubMed Web of Science ®Google Scholar
• GilgerMAToliaVVandenplasYYoussefNNTraxlerBIlluecaMSafety and tolerability of esomeprazole in children with gastroesophageal reflux diseaseJ Pediatr Gastroenterol Nutr20084652453318493207
   PubMed Web of Science ®Google Scholar
• FurutaGTLiacourasCACollinsMHEosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatmentGastroenterology20071331342136317919504
   PubMed Web of Science ®Google Scholar
• CastellDOKahrilasPJRichterJEEsomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitisAm J Gastroenterol20029757558311922549
   PubMed Web of Science ®Google Scholar
• FennertyMBJohansonJFHwangCEfficacy of esomeprazole 40 mg versus lansoprazole 30 mg for healing moderate to severe erosive esophagitisAliment Pharmacol Ther20052145546315709997
   PubMed Web of Science ®Google Scholar
• KahrilasPJFalkGWJohnsonDAEsomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients: A randomized controlled trialAliment Pharmacol Ther2000141249125811012468
   PubMed Web of Science ®Google Scholar
• RichterJEKahrilasPJJohansonJEfficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trialAm J Gastroenterol20019665666511280530
   PubMed Web of Science ®Google Scholar
• GoldBDGunasekaranTToliaVSafety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux diseaseJ Pediatr Gastroenterol Nutr20074552052918030228
   PubMed Web of Science ®Google Scholar
• MoayyediPTalleyNJGastrooesophageal reflux diseaseLancet20063672086210016798392
   PubMed Web of Science ®Google Scholar
• TafuriGTrottaFLeufkensHGMartiniNSaglioccaLTraversaGOff-label use of medicines in children: Can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux diseaseEur J Clin Pharmacol20096584985019396437
   PubMed Web of Science ®Google Scholar
• BocciaGMangusoFMieleEBuonavolontàRStaianoAMaintenance therapy for erosive esophagitis in children after healing by omeprazole: Is it advisableAm J Gastroenterol20071021291129717319927
   PubMed Web of Science ®Google Scholar
• GersonLBRobbinsASGarberAHornbergerJTriadafilopoulosGA cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux diseaseAm J Gastroenterol20009539540710685741
   PubMed Web of Science ®Google Scholar
• HeidelbaughJJGoldbergKLInadomiJMOverutilization of proton pump inhibitors: A review of cost-effectiveness and riskAm J Gastroenterol2009104Suppl 2S273219262544
   PubMedGoogle Scholar
• HassallEDecisions in diagnosing and managing chronic gastroesophageal reflux disease in childrenJ Pediatr2005146Suppl 3S31215758900
   PubMed Web of Science ®Google Scholar
• LachmanLHowdenCWTwenty-four-hour intragastric pH: Tolerance within 5 days of continuous ranitidine administrationAm J Gastroenterol200095576110638559
   PubMed Web of Science ®Google Scholar
• SandvikAKBrennaEWaldumHLReview article: The pharmacological inhibition of gastric acid secretion: tolerance and reboundAliment Pharmacol Ther199711101310189663823
   PubMed Web of Science ®Google Scholar
• PantoflickovaDDortaGRavicMJornodPBlumALAcid inhibition on the first day of dosing: Comparison of four proton pump inhibitorsAliment Pharmacol Ther2003171507151412823153
   PubMed Web of Science ®Google Scholar
• DentJReview article: Pharmacology of esomeprazole and comparisons with omeprazoleAliment Pharmacol Ther200317Suppl 15912614299
   PubMedGoogle Scholar
• OmariTDavidsonGBondarovPNauclérENilssonCLundborgPPharmacokinetics and acid-suppressive effects of esomeprazole in infants 1–24 months old with symptoms of gastroesophageal reflux diseaseJ Pediatr Gastroenterol Nutr20074553053718030229
   PubMed Web of Science ®Google Scholar
• OmariTLundborgPSandströmMPharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux diseaseJ Pediatr200915522222819394048
   PubMed Web of Science ®Google Scholar
• Klinkenberg-KnolECNelisFDentJLong-Term Study GroupLong-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosaGastroenterology200011866166910734017
   PubMed Web of Science ®Google Scholar
• MarchettiFGerarduzziTVenturaAProton pump inhibitors in children: A reviewDig Liver Dis20033573874614620626
   PubMedGoogle Scholar
• CananiRBCirilloPRoggeroPTherapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in childrenPediatrics2006117e817e82016651285
   PubMed Web of Science ®Google Scholar
• WilliamsCMcCollKEReview article: Proton pump inhibitors and bacterial overgrowthAliment Pharmacol Ther20062331016393275
   PubMed Web of Science ®Google Scholar
• BrewsterUCPerazellaMAProton pump inhibitors and the kidney: Critical reviewClin Nephrol200768657217722704
   PubMed Web of Science ®Google Scholar